These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 29524187)

  • 1. Factors That Influence Pancreatic Beta Cell Function and Insulin Resistance in Newly Diagnosed Type 2 Diabetes Patients: A Sub-Analysis of the MARCH Trial.
    Duan Y; Liu J; Xu Y; Yang N; Yang W; Wang G
    Diabetes Ther; 2018 Apr; 9(2):743-752. PubMed ID: 29524187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors that influence the efficacy of acarbose and metformin as initial therapy in Chinese patients with newly diagnosed type 2 diabetes: a subanalysis of the MARCH trial.
    Zhang J; Wang N; Xing X; Yang Z; Wang X; Yang W
    Curr Med Res Opin; 2016; 32(4):713-9. PubMed ID: 26714411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of acarbose therapeutic efficacy in newly diagnosed type 2 diabetes mellitus patients in China.
    Zhang R; Zhao Q; Li R
    BMC Pharmacol Toxicol; 2022 Oct; 23(1):79. PubMed ID: 36258236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MARCH2: comparative assessment of therapeutic effects of acarbose and metformin in newly diagnosed type 2 diabetes patients.
    Wang G; Liu J; Yang N; Gao X; Fan H; Xu Y; Yang W
    PLoS One; 2014; 9(8):e105698. PubMed ID: 25148570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of acarbose and metformin in newly diagnosed type 2 diabetes patients stratified by HbA1c levels.
    Zhang JP; Wang N; Xing XY; Yang ZJ; Wang X; Yang WY
    J Diabetes; 2016 Jul; 8(4):559-67. PubMed ID: 26331290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma Alarin Level and Its Influencing Factors in Obese Newly Diagnosed Type 2 Diabetes Patients.
    Zhou X; Luo M; Zhou S; Cheng Z; Chen Z; Yu X
    Diabetes Metab Syndr Obes; 2021; 14():379-385. PubMed ID: 33536771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term intensive insulin therapy could be the preferred option for new onset Type 2 diabetes mellitus patients with HbA1c > 9.
    Weng J
    J Diabetes; 2017 Oct; 9(10):890-893. PubMed ID: 28661564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].
    Xu Y; Wu P; Wen W; Chen H
    Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1305-1311. PubMed ID: 31852646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saxagliptin Upregulates Nesfatin-1 Secretion and Ameliorates Insulin Resistance and Metabolic Profiles in Type 2 Diabetes Mellitus.
    Chen K; Zhuo T; Wang J; Mei Q
    Metab Syndr Relat Disord; 2018 Sep; 16(7):336-341. PubMed ID: 29912623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
    Li JY; Wu GM; Hou Z; Cao YM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased circulating levels of oxytocin in obesity and newly diagnosed type 2 diabetic patients.
    Qian W; Zhu T; Tang B; Yu S; Hu H; Sun W; Pan R; Wang J; Wang D; Yang L; Mao C; Zhou L; Yuan G
    J Clin Endocrinol Metab; 2014 Dec; 99(12):4683-9. PubMed ID: 25233153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of acarbose and metformin therapy in newly diagnosed type 2 diabetic patients with overweight and/or obesity.
    Sun W; Zeng C; Liao L; Chen J; Wang Y
    Curr Med Res Opin; 2016 Aug; 32(8):1389-96. PubMed ID: 27052634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin plus low-dose glimeperide significantly improves Homeostasis Model Assessment for insulin resistance (HOMA(IR)) and beta-cell function (HOMA(beta-cell)) without hyperinsulinemia in patients with type 2 diabetes mellitus.
    Bermúdez-Pirela VJ; Cano C; Medina MT; Souki A; Lemus MA; Leal EM; Seyfi HA; Cano R; Ciscek A; Bermúdez-Arias F; Contreras F; Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):194-202. PubMed ID: 17414590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin or Acarbose Treatment Significantly Reduced Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus and Low-Grade Albuminuria.
    Pan Q; Xu Y; Yang N; Gao X; Liu J; Yang W; Wang G
    Med Sci Monit; 2018 Dec; 24():8941-8949. PubMed ID: 30531690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic effect of repaglinide or acarbose when added to a double oral antidiabetic treatment with sulphonylureas and metformin: a double-blind, cross-over, clinical trial.
    Derosa G; Salvadeo SA; D'Angelo A; Ferrari I; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
    Curr Med Res Opin; 2009 Mar; 25(3):607-15. PubMed ID: 19232035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review and meta-analysis of
    Pan L; Zhai X; Duan Z; Xu K; Liu G
    Front Pharmacol; 2022; 13():956313. PubMed ID: 36160405
    [No Abstract]   [Full Text] [Related]  

  • 19. [The efficacy and safety of human glucagon-like peptide-1 analogue liraglutide in newly diagnosed type 2 diabetes with glycosylated hemoglobin A1c > 9].
    Yan L; Wang S; Chen P; Chen C; Shao Z; Xu X; Huang Q
    Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):307-12. PubMed ID: 26268058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different Interactive Effects of Metformin and Acarbose With Dietary Macronutrient Intakes on Patients With Type 2 Diabetes Mellitus: Novel Findings From the MARCH Randomized Trial in China.
    An Y; Li Y; Bian N; Ding X; Chang X; Liu J; Wang G
    Front Nutr; 2022; 9():861750. PubMed ID: 35558742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.